NCT00930787

Brief Summary

Support of a ventral hernia repair with a prosthetic mesh has been demonstrated to result in a diminished rate of hernia recurrence. The patient with co-morbidities undergoing hernia repair is at increased risk of wound related complications, which may be exacerbated by the choice of prosthetic mesh, and which are known to influence the ultimate rate of hernia recurrence. It is hypothesized that patients receiving a mesh of biologic origin may experience fewer wound related complications and hence at least an equal rate of hernia recurrence, compared to those receiving a synthetic mesh.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Aug 2009

Shorter than P25 for phase_4

Geographic Reach
1 country

13 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 30, 2009

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

November 20, 2013

Completed
Last Updated

November 20, 2013

Status Verified

September 1, 2013

Enrollment Period

9 months

First QC Date

June 29, 2009

Results QC Date

August 16, 2012

Last Update Submit

September 17, 2013

Conditions

Keywords

hernia repair, surgical mesh, co-morbidities

Outcome Measures

Primary Outcomes (1)

  • Incidence of Surgical Site Events (SSEs)

    Postoperative Day 30

Study Arms (2)

Strattice Reconstructive Tissue Matrix

EXPERIMENTAL

Use of Strattice Reconstructive Tissue Matrix to support hernia repair

Device: Strattice Reconstructive Tissue Matrix (Hernia Repair)

Proceed Surgical Mesh

ACTIVE COMPARATOR

Use of Proceed Surgical Mesh to support hernia repair

Device: Proceed Surgical Mesh (Hernia repair)

Interventions

Hernia repair will be performed, in an open fashion and defect will be closed or reduced in size using musculofascial centralization procedures to reestablish midline.

Strattice Reconstructive Tissue Matrix

Hernia repair will be performed, in an open fashion and defect will be closed or reduced in size using musculofascial centralization procedures to reestablish midline.

Proceed Surgical Mesh

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults of either gender
  • must have 2 or more co-morbidities

You may not qualify if:

  • local or systemic infection
  • expected survival of \<24 months
  • non-ambulatory

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Louisiana Status University Health Sciences Center

New Orleans, Louisiana, 70112, United States

Location

Tulane University

New Orleans, Louisiana, 70115, United States

Location

University of Maryland Medical Center

Baltimore, Maryland, 21201, United States

Location

University of Maryland

Baltimore, Maryland, 21201, United States

Location

Boston Veterans Administration Healthcare System

West Roxbury, Massachusetts, 02132, United States

Location

Hurley Medical Center

Flint, Michigan, 48503, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Truman Medical Center

Kansas City, Missouri, 64108, United States

Location

Long Island Jewish - North Shore

Lake Success, New York, 11042, United States

Location

University Hospital - Case Western

Cleveland, Ohio, 44106, United States

Location

Oregon Health Sciences University

Portland, Oregon, 97239, United States

Location

University of Texas - MD Anderson Cancer Center

Houston, Texas, 70115, United States

Location

Scott & White Medical Center

Temple, Texas, 76508, United States

Location

MeSH Terms

Conditions

Hernia, Ventral

Interventions

Herniorrhaphy

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Plastic Surgery ProceduresSurgical Procedures, Operative

Results Point of Contact

Title
Dr Michael Franz
Organization
LifeCell

Study Officials

  • Robert Martindale, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2009

First Posted

June 30, 2009

Study Start

August 1, 2009

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

November 20, 2013

Results First Posted

November 20, 2013

Record last verified: 2013-09

Locations